Bharat Biotech submits data of Covaxin clinical trials on children
Bharat Biotech said on Wednesday it had submitted data from its Covid-19 vaccine trial in children aged 2 to 18 years to India’s drug regulator, becoming the country’s first company to have tested its shot in very young children. India is turning its focus towards vaccinating children against the coronavirus,Read More